Cargando…
In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547611/ https://www.ncbi.nlm.nih.gov/pubmed/37594497 http://dx.doi.org/10.1007/s00259-023-06398-8 |
| _version_ | 1785115090007097344 |
|---|---|
| author | Holzgreve, Adrien Kunz, Wolfgang G. Mehrens, Dirk Unterrainer, Marcus |
| author_facet | Holzgreve, Adrien Kunz, Wolfgang G. Mehrens, Dirk Unterrainer, Marcus |
| author_sort | Holzgreve, Adrien |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10547611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105476112023-10-05 In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary Holzgreve, Adrien Kunz, Wolfgang G. Mehrens, Dirk Unterrainer, Marcus Eur J Nucl Med Mol Imaging Letter to the Editor Springer Berlin Heidelberg 2023-08-18 2023 /pmc/articles/PMC10547611/ /pubmed/37594497 http://dx.doi.org/10.1007/s00259-023-06398-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Holzgreve, Adrien Kunz, Wolfgang G. Mehrens, Dirk Unterrainer, Marcus In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title | In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title_full | In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title_fullStr | In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title_full_unstemmed | In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title_short | In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary |
| title_sort | in response to: psma pet/ct cost-effectiveness analysis in the usa: a response to a published commentary |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547611/ https://www.ncbi.nlm.nih.gov/pubmed/37594497 http://dx.doi.org/10.1007/s00259-023-06398-8 |
| work_keys_str_mv | AT holzgreveadrien inresponsetopsmapetctcosteffectivenessanalysisintheusaaresponsetoapublishedcommentary AT kunzwolfgangg inresponsetopsmapetctcosteffectivenessanalysisintheusaaresponsetoapublishedcommentary AT mehrensdirk inresponsetopsmapetctcosteffectivenessanalysisintheusaaresponsetoapublishedcommentary AT unterrainermarcus inresponsetopsmapetctcosteffectivenessanalysisintheusaaresponsetoapublishedcommentary |